Invesco Pharmaceuticals ETF
PJP
93 hedge funds and large institutions have $205M invested in Invesco Pharmaceuticals ETF in 2016 Q1 according to their latest regulatory filings, with 11 funds opening new positions, 22 increasing their positions, 45 reducing their positions, and 28 closing their positions.
2% more call options, than puts
Call options by funds: $1.33M | Put options by funds: $1.3M
3.44% less ownership
Funds ownership: 20.97% → 17.53% (-3.4%)
17% less funds holding
Funds holding: 112 → 93 (-19)
33% less funds holding in top 10
Funds holding in top 10: 3 → 2 (-1)
38% less capital invested
Capital invested by funds: $330M → $205M (-$125M)
51% less repeat investments, than reductions
Existing positions increased: 22 | Existing positions reduced: 45
61% less first-time investments, than exits
New positions opened: 11 | Existing positions closed: 28
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$4.3M |
| 2 |
VF
Virtu Financial
New York
|
+$4.15M |
| 3 |
Jane Street
New York
|
+$3.2M |
| 4 |
M&T Bank
Buffalo,
New York
|
+$2.75M |
| 5 |
Bank of America
Charlotte,
North Carolina
|
+$2.73M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
-$21.5M |
| 2 |
LPL Financial
San Diego,
California
|
-$10.9M |
| 3 |
Ameriprise
Minneapolis,
Minnesota
|
-$10.5M |
| 4 |
Wells Fargo
San Francisco,
California
|
-$9.07M |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$4.96M |
PJP Hedge Fund Activity: Q1 2016 in Review
93 of the 3,767 institutional investors tracked by Wall St. Rank reported a position in Invesco Pharmaceuticals ETF (PJP) for Q1 2016, worth a combined $205M — down 38% from $330M a quarter earlier.
Sellers outnumbered buyers: 28 funds closed out of PJP and 11 opened new positions — a net loss of 17 holders — while 45 trimmed existing stakes and 22 added.
The largest buyer was Susquehanna International Group, adding an estimated $4.3M. The largest seller was Morgan Stanley, cutting an estimated $21.5M.
- 93 institutional investors held Invesco Pharmaceuticals ETF (PJP) as of Q1 2016, down from 112 in Q4 2015.
- Funds reported $205M of Invesco Pharmaceuticals ETF stock for Q1 2016, down 38% quarter-over-quarter.
- 11 funds opened new Invesco Pharmaceuticals ETF positions in Q1 2016 and 28 closed out, a net change of -17 holders.
- The largest Invesco Pharmaceuticals ETF buyer in Q1 2016 was Susquehanna International Group, an estimated $4.3M added.
- The largest Invesco Pharmaceuticals ETF seller in Q1 2016 was Morgan Stanley, an estimated $21.5M sold.
Based on aggregated 13F filings for Q1 2016.